Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

PSNL vs NTRA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PSNL
Personalis, Inc.

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$542M
5Y Perf.-48.7%
NTRA
Natera, Inc.

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$29.58B
5Y Perf.+390.5%

PSNL vs NTRA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PSNL logoPSNL
NTRA logoNTRA
IndustryMedical - Diagnostics & ResearchMedical - Diagnostics & Research
Market Cap$542M$29.58B
Revenue (TTM)$52M$2.12B
Net Income (TTM)$-81M$-309M
Gross Margin-3.0%63.7%
Operating Margin-168.4%-16.6%
Total Debt$32M$187M
Cash & Equiv.$124M$946M

PSNL vs NTRALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PSNL
NTRA
StockMay 20May 26Return
Personalis, Inc. (PSNL)10051.3-48.7%
Natera, Inc. (NTRA)100490.5+390.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: PSNL vs NTRA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NTRA leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Personalis, Inc. is the stronger pick specifically for recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
PSNL
Personalis, Inc.
The Defensive Pick

PSNL is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 2.75, Low D/E 12.2%, current ratio 6.76x
  • +51.7% vs NTRA's +38.3%
Best for: sleep-well-at-night
NTRA
Natera, Inc.
The Income Pick

NTRA carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 1.26
  • Rev growth 56.7%, EPS growth 59.5%, 3Y rev CAGR 39.5%
  • 21.5% 10Y total return vs PSNL's -78.7%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthNTRA logoNTRA56.7% revenue growth vs PSNL's -100.0%
Quality / MarginsNTRA logoNTRA-14.6% margin vs PSNL's -155.4%
Stability / SafetyNTRA logoNTRABeta 1.26 vs PSNL's 2.75
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)PSNL logoPSNL+51.7% vs NTRA's +38.3%
Efficiency (ROA)NTRA logoNTRA-17.0% ROA vs PSNL's -24.3%, ROIC -33.3% vs -40.7%

PSNL vs NTRA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PSNLPersonalis, Inc.

Segment breakdown not available.

NTRANatera, Inc.
FY 2025
Product
99.6%$2.3B
Licensing and other
0.4%$10M

PSNL vs NTRA — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLNTRALAGGINGPSNL

Income & Cash Flow (Last 12 Months)

NTRA leads this category, winning 5 of 6 comparable metrics.

NTRA is the larger business by revenue, generating $2.1B annually — 40.5x PSNL's $52M. NTRA is the more profitable business, keeping -14.6% of every revenue dollar as net income compared to PSNL's -155.4%. On growth, NTRA holds the edge at +34.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPSNL logoPSNLPersonalis, Inc.NTRA logoNTRANatera, Inc.
RevenueTrailing 12 months$52M$2.1B
EBITDAEarnings before interest/tax-$80M-$315M
Net IncomeAfter-tax profit-$81M-$309M
Free Cash FlowCash after capex-$79M$94M
Gross MarginGross profit ÷ Revenue-3.0%+63.7%
Operating MarginEBIT ÷ Revenue-168.4%-16.6%
Net MarginNet income ÷ Revenue-155.4%-14.6%
FCF MarginFCF ÷ Revenue-151.9%+4.4%
Rev. Growth (YoY)Latest quarter vs prior year-100.0%+34.7%
EPS Growth (YoY)Latest quarter vs prior year-13.0%-146.2%
NTRA leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

Evenly matched — PSNL and NTRA each lead in 1 of 2 comparable metrics.
MetricPSNL logoPSNLPersonalis, Inc.NTRA logoNTRANatera, Inc.
Market CapShares × price$542M$29.6B
Enterprise ValueMkt cap + debt − cash$449M$28.8B
Trailing P/EPrice ÷ TTM EPS-6.67x-140.58x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue17.43x
Price / BookPrice ÷ Book value/share2.07x22.44x
Price / FCFMarket cap ÷ FCF427.23x
Evenly matched — PSNL and NTRA each lead in 1 of 2 comparable metrics.

Profitability & Efficiency

NTRA leads this category, winning 7 of 9 comparable metrics.

NTRA delivers a -24.7% return on equity — every $100 of shareholder capital generates $-25 in annual profit, vs $-31 for PSNL. PSNL carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to NTRA's 0.16x. On the Piotroski fundamental quality scale (0–9), NTRA scores 6/9 vs PSNL's 4/9, reflecting solid financial health.

MetricPSNL logoPSNLPersonalis, Inc.NTRA logoNTRANatera, Inc.
ROE (TTM)Return on equity-31.1%-24.7%
ROA (TTM)Return on assets-24.3%-17.0%
ROICReturn on invested capital-40.7%-33.3%
ROCEReturn on capital employed-33.0%-18.1%
Piotroski ScoreFundamental quality 0–946
Debt / EquityFinancial leverage0.12x0.16x
Net DebtTotal debt minus cash-$92M-$758M
Cash & Equiv.Liquid assets$124M$946M
Total DebtShort + long-term debt$32M$187M
Interest CoverageEBIT ÷ Interest expense-5215.45x-69.90x
NTRA leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

NTRA leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in NTRA five years ago would be worth $22,333 today (with dividends reinvested), compared to $2,821 for PSNL. Over the past 12 months, PSNL leads with a +51.7% total return vs NTRA's +38.3%. The 3-year compound annual growth rate (CAGR) favors NTRA at 59.4% vs PSNL's 38.8% — a key indicator of consistent wealth creation.

MetricPSNL logoPSNLPersonalis, Inc.NTRA logoNTRANatera, Inc.
YTD ReturnYear-to-date-22.7%-6.0%
1-Year ReturnPast 12 months+51.7%+38.3%
3-Year ReturnCumulative with dividends+167.4%+305.1%
5-Year ReturnCumulative with dividends-71.8%+123.3%
10-Year ReturnCumulative with dividends-78.7%+2147.5%
CAGR (3Y)Annualised 3-year return+38.8%+59.4%
NTRA leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

NTRA leads this category, winning 2 of 2 comparable metrics.

NTRA is the less volatile stock with a 1.26 beta — it tends to amplify market swings less than PSNL's 2.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NTRA currently trades 83.9% from its 52-week high vs PSNL's 52.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPSNL logoPSNLPersonalis, Inc.NTRA logoNTRANatera, Inc.
Beta (5Y)Sensitivity to S&P 5002.75x1.26x
52-Week HighHighest price in past year$11.50$256.36
52-Week LowLowest price in past year$3.84$131.81
% of 52W HighCurrent price vs 52-week peak+52.8%+83.9%
RSI (14)Momentum oscillator 0–10040.051.9
Avg Volume (50D)Average daily shares traded1.8M1.3M
NTRA leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates PSNL as "Buy" and NTRA as "Buy". Consensus price targets imply 85.3% upside for PSNL (target: $11) vs 22.0% for NTRA (target: $263).

MetricPSNL logoPSNLPersonalis, Inc.NTRA logoNTRANatera, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$11.25$262.50
# AnalystsCovering analysts1227
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

NTRA leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.

Best OverallNatera, Inc. (NTRA)Leads 4 of 6 categories
Loading custom metrics...

PSNL vs NTRA: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is PSNL or NTRA a better buy right now?

For growth investors, Natera, Inc.

(NTRA) is the stronger pick with 56. 7% revenue growth year-over-year, versus -100. 0% for Personalis, Inc. (PSNL). Analysts rate Personalis, Inc. (PSNL) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — PSNL or NTRA?

Over the past 5 years, Natera, Inc.

(NTRA) delivered a total return of +123. 3%, compared to -71. 8% for Personalis, Inc. (PSNL). Over 10 years, the gap is even starker: NTRA returned +21. 5% versus PSNL's -78. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — PSNL or NTRA?

By beta (market sensitivity over 5 years), Natera, Inc.

(NTRA) is the lower-risk stock at 1. 26β versus Personalis, Inc. 's 2. 75β — meaning PSNL is approximately 119% more volatile than NTRA relative to the S&P 500. On balance sheet safety, Personalis, Inc. (PSNL) carries a lower debt/equity ratio of 12% versus 16% for Natera, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — PSNL or NTRA?

By revenue growth (latest reported year), Natera, Inc.

(NTRA) is pulling ahead at 56. 7% versus -100. 0% for Personalis, Inc. (PSNL). On earnings-per-share growth, the picture is similar: Natera, Inc. grew EPS 59. 5% year-over-year, compared to 33. 6% for Personalis, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — PSNL or NTRA?

Natera, Inc.

(NTRA) is the more profitable company, earning -11. 2% net margin versus -155. 4% for Personalis, Inc. — meaning it keeps -11. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NTRA leads at -13. 1% versus -168. 4% for PSNL. At the gross margin level — before operating expenses — NTRA leads at 60. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — PSNL or NTRA?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is PSNL or NTRA better for a retirement portfolio?

For long-horizon retirement investors, Natera, Inc.

(NTRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 26)). Personalis, Inc. (PSNL) carries a higher beta of 2. 75 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NTRA: +21. 5%, PSNL: -78. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between PSNL and NTRA?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: PSNL is a small-cap quality compounder stock; NTRA is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

PSNL

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

NTRA

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 17%
  • Gross Margin > 38%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform PSNL and NTRA on the metrics below

Revenue Growth>
%
(PSNL: -100.0% · NTRA: 34.7%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.